Diagnosis and management of migraine in ten steps
File(s)Diagnosis and management of migraine in ten steps.pdf (1.35 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Migraine is a disabling primary headache disorder that directly affects more than one billion people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed and under-treated. To support clinical decision-making, we convened a European panel of experts to develop a ten-step approach to the diagnosis and management of migraine. Each step was established by expert consensus and supported by a review of current literature, and the Consensus Statement is endorsed by the European Headache Federation and the European Academy of Neurology. In this Consensus Statement, we introduce typical clinical features, diagnostic criteria and differential diagnoses of migraine. We then emphasize the value of patient centricity and patient education to ensure treatment adherence and satisfaction with care provision. Further, we outline best practices for acute and preventive treatment of migraine in various patient populations, including adults, children and adolescents, pregnant and breastfeeding women, and older people. In addition, we provide recommendations for evaluating treatment response and managing treatment failure. Lastly, we discuss the management of complications and comorbidities as well as the importance of planning long-term follow-up.
Date Issued
2021-06-18
Date Acceptance
2021-05-07
Citation
Nature Reviews Neurology, 2021, 17 (8), pp.501-514
ISSN
1759-4758
Publisher
Nature Research
Start Page
501
End Page
514
Journal / Book Title
Nature Reviews Neurology
Volume
17
Issue
8
Copyright Statement
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663266800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Neurosciences & Neurology
MEDICATION-OVERUSE HEADACHE
PLACEBO-CONTROLLED TRIAL
TENSION-TYPE HEADACHE
DOUBLE-BLIND
EPISODIC MIGRAINE
PHARMACOLOGICAL-TREATMENT
PROPHYLACTIC TREATMENT
MENSTRUAL MIGRAINE
BRIEF INTERVENTION
POPULATION
Publication Status
Published
Date Publish Online
2021-06-18